EW241220P55000
- 0.05
- 0.000.00%
Edwards Lifesciences Newsroom
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
Barclays Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $88
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December Starts With a Mixed Market | Live Stock
Edwards Lifesciences Price Target Raised to $88.00/Share From $85.00 by Barclays
Barclays Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $88
Wells Fargo Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $80
Edwards Lifesciences Corporation's (NYSE:EW) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Edwards Lifesciences (EW) Receives a Hold From Leerink Partners
Wednesday Ends With Index Decline | Wall Street Today
The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts
Edwards Lifesciences Analyst Ratings
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
RBC Capital Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $80
RBC Raises Price Target on Edwards Lifesciences to $80 From $75, Keeps Outperform Rating
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today